Genmab revenue and financials
In the fiscal year ended December 2025, Genmab reported revenue of $3.72B (+19.19% year over year). Net income was $963M, a net margin of 25.9%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +19.19%
- 2025 vs 2024
- Net income growth
- −15.00%
- 2025 vs 2024
- Net margin
- 25.9%
- 2024: 36.3%
How Genmab is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 17.5% a year on average over the last 5 years
Compound annual growth rate: from $1.66B in 2020 to $3.72B in 2025.
Revenue has grown for 4 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin fell from 43.2% to 33.6%
Operating income over revenue, 2022 → 2025: 9.6 percentage points.
Profits turn into cash: free cash flow equal to 120% of net income
Totals for fiscal years 2023–2025: free cash flow $3.27B, net income $2.73B.
Shares outstanding down 4.8% in 5 years
Average diluted shares, 2020 → 2025: with fewer shares, each one represents a larger stake in the company.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3,720 | 3,121 | 2,390 | 2,088 | 1,287 | 1,660 | 805 | 465 | 381 | 257 |
| Cost of revenue | 238 | 143 | 33.0 | 0.0 | — | — | — | — | — | — |
| Gross profit | 3,482 | 2,978 | 2,357 | 2,088 | 1,287 | 1,660 | 805 | 465 | 381 | 257 |
| Selling, general and administrative | 626 | 549 | 478 | 385 | 196 | 108 | 51.3 | 32.9 | 23.7 | 14.5 |
| Research and development | 1,606 | 1,414 | 1,107 | 801 | 639 | 515 | 358 | 220 | 137 | 93.6 |
| Operating income | 1,250 | 1,015 | 772 | 902 | 451 | 1,036 | 396 | 212 | 220 | 149 |
| EBIT | 1,250 | 1,015 | 772 | 902 | 451 | 1,036 | 396 | 212 | 220 | 149 |
| EBITDA | 1,290 | 1,052 | 802 | 944 | 481 | 1,074 | 417 | 225 | 228 | 155 |
| Interest expense | 61.0 | 18.0 | 10.0 | 5.6 | 2.0 | 1.6 | 1.1 | 11.0 | 0.5 | 0.0 |
| Pre-tax income | 1,204 | 1,326 | 817 | 1,000 | 599 | 969 | 429 | 248 | 171 | 160 |
| Income tax | 241 | 193 | 186 | 215 | 147 | 188 | 104 | 21.5 | -6.4 | -8.0 |
| Net income | 963 | 1,133 | 631 | 785 | 452 | 781 | 325 | 226 | 178 | 168 |
| Net income to common shareholders | 963 | 1,133 | 631 | 785 | 452 | 781 | 325 | 226 | 178 | 168 |
| Basic EPS | 15.49 | 17.65 | 9.66 | 12.00 | 6.91 | 11.98 | 5.16 | 3.69 | 2.92 | 2.81 |
| Diluted EPS | 15.37 | 17.53 | 9.58 | 11.89 | 6.85 | 11.85 | 5.11 | 3.64 | 2.86 | 2.72 |
| Average shares (basic) | 62.2 | 64.2 | 65.3 | 65.4 | 65.4 | 65.2 | 63.0 | 61.3 | 60.8 | 59.9 |
| Average shares (diluted) | 62.7 | 64.7 | 65.9 | 66.0 | 66.0 | 65.9 | 63.6 | 62.0 | 62.1 | 61.8 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,187 | 1,155 | 896 | 1,058 | 1,022 | 925 | 715 | 1,027 | 829 | 779 | 603 | 706 |
| Cost of revenue | 88.0 | 84.0 | 65.0 | 81.0 | 58.0 | 57.0 | 42.0 | 53.0 | 40.8 | 28.0 | 27.0 | 18.7 |
| Gross profit | 1,099 | 1,071 | 831 | 977 | 964 | 868 | 673 | 974 | 788 | 751 | 576 | 687 |
| Selling, general and administrative | 196 | 205 | 166 | 208 | 148 | 144 | 126 | 196 | 129 | 129 | 125 | 139 |
| Research and development | 451 | 459 | 440 | 526 | 354 | 364 | 359 | 431 | 341 | 361 | 335 | 289 |
| Operating income | 441 | 407 | 225 | 243 | 459 | 360 | 188 | 347 | 317 | 261 | 116 | 260 |
| EBIT | 441 | 407 | 225 | 243 | 459 | 360 | 188 | 347 | 317 | 261 | 116 | 260 |
| EBITDA | 444 | 423 | 244 | 253 | 465 | 376 | 204 | 353 | 330 | 271 | 126 | 265 |
| Interest expense | 111 | 110 | 112 | 44.0 | 3.0 | 9.0 | 5.0 | 8.8 | 2.7 | 3.0 | 4.0 | 3.1 |
| Pre-tax income | 354 | 295 | 74.0 | 55.0 | 482 | 423 | 244 | 554 | 257 | 307 | 249 | 149 |
| Income tax | 12.0 | -8.0 | 21.0 | 24.0 | 81.0 | 87.0 | 49.0 | -24.0 | 67.8 | 104 | 57.0 | 45.1 |
| Net income | 342 | 303 | 53.0 | 31.0 | 401 | 336 | 195 | 578 | 189 | 203 | 192 | 104 |
| Net income to common shareholders | 342 | 303 | 53.0 | 31.0 | 401 | 336 | 195 | 578 | 189 | 203 | 192 | 104 |
| Basic EPS | 5.58 | 4.94 | 0.84 | 0.50 | 6.51 | 5.44 | 3.06 | 9.10 | 2.98 | 3.15 | 2.96 | 1.60 |
| Diluted EPS | 5.51 | 4.91 | 0.83 | 0.50 | 6.46 | 5.42 | 3.05 | 9.00 | 2.96 | 3.13 | 2.94 | 1.58 |
| Average shares (basic) | 61.3 | 61.3 | 63.1 | 61.6 | 61.6 | 61.8 | 63.7 | 63.5 | 63.5 | 64.4 | 64.9 | 65.3 |
| Average shares (diluted) | 62.1 | 61.7 | 63.9 | 63.1 | 62.1 | 62.0 | 63.9 | 64.2 | 63.9 | 64.9 | 65.3 | 66.1 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12,873 | 6,414 | 5,232 | 4,336 | 3,765 | 3,470 | 2,273 | 1,300 | 1,064 | 742 |
| Current assets | 2,885 | 3,900 | 4,912 | 4,062 | 3,476 | 3,084 | 2,096 | 1,142 | 977 | 693 |
| Cash and equivalents | 1,715 | 1,380 | 2,204 | 1,424 | 1,369 | 1,192 | 533 | 81.9 | 217 | 43.5 |
| Short-term investments | 0.0 | 1,574 | 1,967 | 1,789 | 1,587 | 1,448 | 1,114 | 856 | 657 | 512 |
| Receivables | 1,152 | 937 | 733 | 848 | 520 | 445 | 449 | 204 | 103 | 138 |
| Inventory | 18.0 | 9.0 | 8.0 | 0.0 | — | — | — | — | — | — |
| Net property, plant and equipment | 280 | 265 | 244 | 190 | 149 | 121 | 62.1 | 24.9 | 18.3 | 4.6 |
| Goodwill | 355 | 355 | — | — | — | — | — | — | — | — |
| Other intangible assets | 9,123 | 1,728 | 15.0 | 21.0 | 38.8 | 55.5 | 70.5 | 72.2 | 20.1 | 25.8 |
| Long-term investments | 37.0 | 32.0 | 20.0 | 19.1 | 56.7 | 177 | 22.4 | — | — | — |
| Current liabilities | 1,427 | 744 | 368 | 262 | 240 | 206 | 141 | 68.2 | 52.7 | 58.3 |
| Accounts payable | — | — | — | — | 53.5 | — | — | — | — | 3.2 |
| Long-term debt | 5,001 | 0.0 | — | — | — | — | — | — | — | — |
| Total debt | 5,426 | 144 | 114 | 85.9 | 65.0 | 52.4 | 27.2 | — | — | — |
| Total liabilities | 7,026 | 1,277 | 545 | 408 | 372 | 332 | 165 | 68.7 | 53.3 | 58.3 |
| Total equity (incl. minority) | 5,847 | 5,137 | 4,687 | 3,927 | 3,394 | 3,139 | 2,109 | 1,231 | 1,011 | 683 |
| Retained earnings | 4,098 | 3,392 | 2,737 | 2,132 | 1,532 | 1,167 | 320 | -30.4 | -299 | -440 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12,936 | 12,515 | 12,376 | 12,873 | 7,021 | 6,464 | 6,586 | 6,414 | 5,932 | 5,549 | 5,305 | 5,233 |
| Current assets | 3,188 | 2,801 | 2,573 | 2,885 | 4,471 | 3,910 | 4,037 | 3,900 | 3,544 | 3,152 | 4,971 | 4,914 |
| Cash and equivalents | 1,860 | 1,503 | 1,521 | 1,715 | 1,761 | 1,296 | 1,619 | 1,380 | 949 | 622 | 2,122 | 2,205 |
| Short-term investments | — | — | — | 0.0 | 1,650 | 1,603 | 1,607 | 1,574 | — | 1,638 | 2,157 | 1,968 |
| Receivables | 1,287 | 1,273 | 1,027 | 1,152 | 1,046 | 998 | 799 | 937 | 944 | 886 | 677 | 734 |
| Inventory | 30.0 | 18.0 | 21.0 | 18.0 | 14.0 | 13.0 | 12.0 | 9.0 | 10.6 | 5.2 | 15.3 | 8.5 |
| Net property, plant and equipment | 314 | 254 | 265 | 280 | 266 | 277 | 271 | 265 | 269 | 270 | 269 | 243 |
| Goodwill | 355 | 355 | 355 | 355 | 355 | 355 | 355 | 355 | 360 | 362 | — | — |
| Other intangible assets | 8,842 | 8,872 | 8,948 | 9,123 | 1,748 | 1,752 | 1,756 | 1,728 | 1,721 | 1,726 | 3.3 | 15.0 |
| Long-term investments | 44.0 | 39.0 | 41.0 | 37.0 | 36.0 | 35.0 | 30.0 | 32.0 | 28.3 | 28.2 | 22.1 | 19.9 |
| Current liabilities | 1,299 | 1,140 | 1,178 | 1,427 | 741 | 629 | 756 | 744 | 686 | 627 | 399 | 368 |
| Long-term debt | 4,674 | 4,841 | 4,933 | 5,001 | — | — | — | — | — | — | — | — |
| Total debt | 5,198 | 5,273 | 5,351 | 5,426 | 142 | 148 | 143 | 144 | 147 | 146 | 146 | — |
| Total liabilities | 6,603 | 6,558 | 6,694 | 7,026 | 1,270 | 1,162 | 1,290 | 1,277 | 1,157 | 1,099 | 605 | 546 |
| Total equity (incl. minority) | 6,333 | 5,957 | 5,682 | 5,847 | 5,751 | 5,302 | 5,296 | 5,137 | 4,774 | 4,449 | 4,700 | 4,688 |
| Retained earnings | 4,801 | 4,421 | 4,090 | 4,098 | 4,032 | 3,598 | 3,537 | 3,392 | 2,935 | 2,605 | 2,864 | 2,821 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,186 | 1,126 | 1,071 | 563 | 341 | 1,056 | 199 | 156 | 256 | 46.4 |
| Depreciation and amortization | 57.0 | 52.0 | 43.0 | 52.1 | 29.7 | 43.7 | 25.1 | 13.5 | 7.7 | 5.8 |
| Capital expenditure | -37.0 | -27.0 | -53.0 | -45.6 | -38.5 | -50.4 | -11.9 | -11.1 | -14.3 | -1.7 |
| Investing cash flow | -5,643 | -1,447 | -185 | -397 | -147 | -386 | -298 | -273 | -108 | -144 |
| Financing cash flow | 4,789 | -566 | -89.0 | -114 | -64.2 | 11.7 | 549 | -10.9 | 34.6 | 12.9 |
| Share repurchases | -448 | -576 | -96.0 | -143 | -76.0 | -4.1 | -1.4 | -22.4 | — | -16.7 |
| Debt issued | 5,500 | — | — | — | — | — | — | — | — | — |
| Debt repaid | -13.0 | -9.0 | -14.0 | -10.5 | -8.9 | -7.2 | -4.7 | — | — | -0.0 |
| Effect of exchange rates | 3.0 | 63.0 | -12.0 | 82.6 | 130 | -73.0 | 2.4 | 2.9 | -15.4 | 4.1 |
| Net change in cash | 335 | -824 | 785 | 135 | 259 | 609 | 453 | -125 | 168 | -80.3 |
| Free cash flow | 1,149 | 1,099 | 1,018 | 517 | 302 | — | — | — | — | — |
| Levered free cash flow | 1,068 | 915 | 778 | 306 | 260 | 767 | 97.9 | -1.5 | 184 | -12.0 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 520 | 51.0 | 3.0 | 301 | 536 | 62.0 | 287 | 424 | 304 | 219 | 219 | 248 |
| Depreciation and amortization | 17.0 | 16.0 | 19.0 | 15.0 | 18.0 | 16.0 | 16.0 | 10.6 | 16.8 | 14.0 | 13.0 | 8.6 |
| Capital expenditure | -4.0 | -2.0 | -5.0 | -13.0 | -2.0 | -10.0 | -12.0 | -14.1 | -5.7 | -4.0 | -4.0 | -9.9 |
| Investing cash flow | -9.0 | 2.0 | -9.0 | -5,572 | -54.0 | 26.0 | -43.0 | -60.3 | 33.5 | -1,270 | -210 | -65.5 |
| Financing cash flow | -151 | -75.0 | -177 | 5,229 | -21.0 | -406 | -13.0 | -21.5 | -41.3 | -440 | -85.0 | -3.3 |
| Share repurchases | 0.0 | -9.0 | -110 | -3.0 | -25.0 | -408 | -12.0 | -23.5 | -45.2 | -439 | -91.0 | -0.9 |
| Debt issued | — | — | — | 5,500 | — | — | — | — | — | — | — | — |
| Debt repaid | -164 | -65.0 | -69.0 | -2.0 | -5.0 | -4.0 | -2.0 | -0.7 | -2.5 | -3.0 | -3.0 | -3.7 |
| Effect of exchange rates | -3.0 | 4.0 | -11.0 | -4.0 | 4.0 | -5.0 | 8.0 | 17.6 | 4.5 | -14.0 | -1.0 | -91.1 |
| Net change in cash | 357 | -18.0 | -194 | -46.0 | 465 | -323 | 239 | 359 | 301 | -1,505 | -77.0 | 88.1 |
| Free cash flow | 516 | 49.0 | -2.0 | 288 | 534 | 52.0 | 275 | 410 | 298 | 215 | 215 | 238 |
| Levered free cash flow | 344 | -67.4 | 33.6 | 469 | 364 | -104 | 271 | 278 | 213 | 200 | 174 | 193 |
Financial statements of similar companies
Companies in the group: same industry, similar size
